Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
MIRM
MIRM
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
MIRM News
Mirum Pharmaceuticals Unveils New Liver Disease Treatment Data
1d ago
Newsfilter
Mirum Pharmaceuticals Completes $600M Convertible Note Offering
May 13 2026
seekingalpha
Mirum Pharmaceuticals Prices $600 Million Convertible Notes Offering
May 13 2026
Newsfilter
Mirum Pharmaceuticals Q1 2026 Earnings Call Insights
May 07 2026
seekingalpha
Mirum's Drug Trial Shows Significant Itch Relief in Liver Disease
May 04 2026
stocktwits
Mirum Pharmaceuticals' VISTAS Study Achieves Success
May 04 2026
NASDAQ.COM
Mirum Pharmaceuticals to Report VISTAS Trial Results Today
May 04 2026
NASDAQ.COM
Mirum Pharmaceuticals to Host Investor Call on VISTAS Study Results
May 03 2026
Newsfilter
Mirum Pharmaceuticals' AZURE-1 Study Achieves Key Endpoint
Apr 27 2026
NASDAQ.COM
Vertex and Mirum Pharmaceuticals Market Dynamics
Apr 19 2026
NASDAQ.COM
Vertex and Mirum: Biotech Investment Opportunities
Apr 19 2026
Fool
Mirum Pharmaceuticals: A Rising Star in Biotech
Apr 13 2026
Fool
Mirum Pharmaceuticals to Report Four Key Clinical Readouts in Next 18 Months
Apr 13 2026
NASDAQ.COM
ClearBridge SMID Cap Growth Strategy Outperforms Benchmark in Q1 2026
Apr 09 2026
seekingalpha
Mirum (MIRM) Q1 2025 Earnings Call Transcript
Apr 01 2026
NASDAQ.COM
Mirum Pharmaceuticals Grants Stock Options and RSUs to New Employees
Mar 12 2026
Newsfilter
Show More News
